USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41530
Submission : 2025-03-30
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41530
Submission : 2025-03-30
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FINISHED DOSAGE FORMULATIONS
Drug : TRICOR
Dosage Form : TABLET; ORAL
Application Number : 21656
Country : US
Patented : No
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50698
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : TABLET; ORAL
Application Number : 50662
Country : US
Patented : No
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 202209
Country : US
Patented : No
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 90098
Country : US
Patented : No
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 206094
Country : US
Patented : No
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Drug : IMIQUIMOD
Dosage Form : CREAM; TOPICAL
Application Number : 202002
Country : US
Patented : No
OMEPRAZOLE; SODIUM BICARBONATE
Drug : OMEPRAZOLE AND SODIUM BICARBONATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 79182
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
04 Feb 2025
Reply
21 Jun 2024
Reply
04 Mar 2024
Reply
14 Oct 2023
Reply
11 Oct 2023
Reply
06 Oct 2023
Reply
16 Jun 2023
Reply
14 Feb 2023
Reply
15 Jul 2022
Reply
05 Jul 2022